Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)

NCT04349046 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT04349046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2021
Completion date
December 31, 2025
Enrollment
332 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis of hip, congenital hip dysplasia, femoral neck fractures, inflammatory arthritis, osteoarthritis, hip, rheumatoid arthritis